Vivante Health Receives $31 Million Investment

Vivante Health, the leader in digital digestive health, announced the closing of a $31 million Series B financing led by new investor Mercato Partners. The round also includes new capital from Health Catalyst Capital, as well as investors 7wireVentures, Intermountain Ventures, Distributed Ventures, Human Capital and SemperVirens. This reflects the proven ability of Vivante's GIThrive platform to improve patient outcomes at scale and reduce medical costs in a region. The latest investment brings Vivante's total capital raised to date to $47 million, following a $16 million Series A round in late 2021.

Also See: Electrify Video Partners Receives $85 Million Investment

Vivante Health

The new funding comes on the heels of recent GIThrive enhancements that highlight the platform's unique ability to provide the right care at the right time. In addition to food and symptom registration, online educational resources and 24/7 access to dietitians, health coaches and nurses, users now receive AI-driven personalised care plans that dynamically adapt to their symptoms and other variables. Access to a nationwide network of internists and gastroenterologists for diagnosis, treatment, lab test orders and prescriptions; and other new services that help bridge the gap between virtual and real-world care.